A detailed history of Victory Capital Management Inc transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Victory Capital Management Inc holds 66,279 shares of SRPT stock, worth $7.23 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
66,279
Previous 83,073 20.22%
Holding current value
$7.23 Million
Previous $13.1 Million 36.93%
% of portfolio
0.01%
Previous 0.01%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$124.33 - $156.75 $2.09 Million - $2.63 Million
-16,794 Reduced 20.22%
66,279 $8.28 Million
Q2 2024

Aug 05, 2024

BUY
$113.33 - $163.85 $1.26 Million - $1.82 Million
11,087 Added 15.4%
83,073 $13.1 Million
Q1 2024

May 03, 2024

SELL
$93.7 - $141.53 $285,410 - $431,100
-3,046 Reduced 4.06%
71,986 $9.32 Million
Q4 2023

Feb 05, 2024

SELL
$67.31 - $124.76 $831,547 - $1.54 Million
-12,354 Reduced 14.14%
75,032 $7.24 Million
Q3 2023

Nov 06, 2023

BUY
$102.5 - $123.59 $1.32 Million - $1.59 Million
12,894 Added 17.31%
87,386 $10.6 Million
Q2 2023

Jul 27, 2023

SELL
$106.4 - $157.19 $333,564 - $492,790
-3,135 Reduced 4.04%
74,492 $8.53 Million
Q1 2023

May 02, 2023

BUY
$117.53 - $155.99 $2.39 Million - $3.17 Million
20,350 Added 35.53%
77,627 $10.7 Million
Q4 2022

Feb 10, 2023

BUY
$100.86 - $132.13 $8,573 - $11,231
85 Added 0.15%
57,277 $7.42 Million
Q4 2022

Feb 09, 2023

SELL
$100.86 - $132.13 $14 Million - $18.4 Million
-139,262 Reduced 70.89%
57,192 $7.41 Million
Q3 2022

Nov 02, 2022

BUY
$75.71 - $119.24 $12.2 Million - $19.2 Million
160,708 Added 449.58%
196,454 $21.7 Million
Q2 2022

Aug 01, 2022

SELL
$62.69 - $88.44 $1.09 Million - $1.53 Million
-17,322 Reduced 32.64%
35,746 $2.68 Million
Q1 2022

May 04, 2022

SELL
$63.15 - $90.42 $36.6 Million - $52.4 Million
-579,212 Reduced 91.61%
53,068 $4.08 Million
Q4 2021

Feb 07, 2022

BUY
$77.28 - $99.42 $48 Million - $61.8 Million
621,740 Added 5898.86%
632,280 $56.9 Million
Q3 2021

Nov 02, 2021

BUY
$65.97 - $92.48 $40,241 - $56,412
610 Added 6.14%
10,540 $975,000
Q2 2021

Aug 03, 2021

SELL
$69.38 - $86.75 $9,296 - $11,624
-134 Reduced 1.33%
9,930 $772,000
Q1 2021

May 04, 2021

SELL
$72.25 - $168.95 $1.4 Million - $3.27 Million
-19,342 Reduced 65.78%
10,064 $750,000
Q4 2020

Feb 01, 2021

SELL
$125.56 - $178.74 $439,711 - $625,947
-3,502 Reduced 10.64%
29,406 $5.01 Million
Q3 2020

Nov 09, 2020

BUY
$127.12 - $172.34 $2.75 Million - $3.73 Million
21,631 Added 191.82%
32,908 $4.62 Million
Q2 2020

Aug 07, 2020

SELL
$93.0 - $171.7 $13,671 - $25,239
-147 Reduced 1.29%
11,277 $1.81 Million
Q1 2020

May 04, 2020

SELL
$82.38 - $131.64 $3,295 - $5,265
-40 Reduced 0.35%
11,424 $1.12 Million
Q4 2019

Feb 06, 2020

BUY
$76.53 - $135.58 $68,647 - $121,615
897 Added 8.49%
11,464 $1.48 Million
Q4 2019

Feb 04, 2020

SELL
$76.53 - $135.58 $90,534 - $160,391
-1,183 Reduced 10.07%
10,567 $1.23 Million
Q3 2019

Nov 12, 2019

BUY
$72.81 - $156.91 $855,517 - $1.84 Million
11,750 New
11,750 $885,000

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $9.55B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.